Lewis Jonathan Insider Trades

Insider Trading History

Track insider trading activity for Lewis Jonathan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $917k 350,000 shares
Last Trade
Dec 31, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266M 350,000 shares
$760.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.95M 744,145 shares
Last Trade
Dec 30, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.8M 34,261 shares
$754.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $0 0 shares
Last Trade
Jan 06, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$156M 242,979 shares
$640.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $2.04M 778,406 shares
Last Trade
Jan 06, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$156M 242,979 shares
$640.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.4M 535,427 shares
Last Trade
Jan 06, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.4M 25,674 shares
$640.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.34M 509,753 shares
Last Trade
Dec 31, 2013 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.78M 15,023 shares
$651.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $786k 300,000 shares
Last Trade
Dec 31, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195M 300,000 shares
$651.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $865k 330,000 shares
Last Trade
Jun 27, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114M 330,000 shares
$345.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.37M 524,776 shares
Last Trade
Dec 31, 2012 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.4M 21,475 shares
$624.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.43M 546,251 shares
Last Trade
Dec 31, 2012 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.18M 14,715 shares
$624.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $786k 300,000 shares
Last Trade
Dec 31, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187M 300,000 shares
$624.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.47M 560,516 shares
Last Trade
Dec 31, 2011 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.2M 21,475 shares
$661.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.52M 581,991 shares
Last Trade
Dec 30, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68M 102,781 shares
$661.50
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
CEO
Holding Value $1.26M 479,510 shares
Last Trade
Jan 08, 2011 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.7M 15,190 shares
$771.00
$2.62
Ziopharm Oncology
Ziopharm Oncology ZIOP
CEO
Holding Value $130k 150,000 shares
Last Trade
Dec 31, 2010 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$699k 150,000 shares
$4.66
$0.87
Ziopharm Oncology
Ziopharm Oncology ZIOP
CEO
Holding Value $428k 494,700 shares
Last Trade
Dec 31, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$102k 21,475 shares
$4.77
$0.87
Ziopharm Oncology
Ziopharm Oncology ZIOP
CEO
Holding Value $447k 516,175 shares
Last Trade
Sep 23, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$509k 128,850 shares
$3.95
$0.87
Ziopharm Oncology
Ziopharm Oncology ZIOP
CEO
Holding Value $558k 645,025 shares
Last Trade
Jan 08, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.2k 12,650 shares
$3.10
$0.87
Ziopharm Oncology
Ziopharm Oncology ZIOP
CEO
Holding Value $569k 657,675 shares
Last Trade
Dec 31, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 150,000 shares
$2.96
$0.87
Ziopharm Oncology
Ziopharm Oncology ZIOP
CEO
Holding Value $130k 150,000 shares
Last Trade
Dec 31, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 150,000 shares
$2.96
$0.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up